Brii Biosciences Limited
BRIBF
$0.2406
$0.00944.07%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -70.63M | -53.76M | -36.82M | -31.00M | -25.34M |
| Total Depreciation and Amortization | 1.17M | 1.47M | 1.77M | 1.96M | 2.16M |
| Total Amortization of Deferred Charges | 56.00K | 56.00K | 55.70K | 55.70K | 55.70K |
| Total Other Non-Cash Items | 24.61M | 5.89M | -12.85M | -28.51M | -44.50M |
| Change in Net Operating Assets | -7.02M | -11.88M | -16.70M | -16.70M | -16.70M |
| Cash from Operations | -51.81M | -58.23M | -64.54M | -74.19M | -84.32M |
| Capital Expenditure | -449.30K | -278.10K | -106.10K | -53.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 124.97M | 107.19M | 89.18M | 36.71M | -16.60M |
| Cash from Investing | 124.52M | 106.91M | 89.07M | 36.66M | -16.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.87M | -7.60M | -8.32M | -8.91M | -9.50M |
| Issuance of Common Stock | 53.00K | 72.50K | 92.00K | 135.50K | 179.00K |
| Repurchase of Common Stock | -220.00K | -691.00K | -1.16M | -1.16M | -1.16M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.37M | -1.80M | -1.23M | -861.50K | -494.00K |
| Cash from Financing | -1.31M | -1.39M | -1.47M | -1.51M | -1.55M |
| Foreign Exchange rate Adjustments | 73.50K | 206.50K | 340.40K | 772.80K | 1.22M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.48M | 47.50M | 23.40M | -38.27M | -101.25M |